Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma

NCT05178524 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Gut Microbiota
Hepatocellular Carcinoma
Bifidobacterium

Interventions

DRUG: BIFICO

Sponsor

Tongji Hospital